Convenience and patient compliance drive contract packager's business

Tee Noland, director of business development for Pharma Tech Industries (PTI), a contract manufacturer/packager, shares his views on why pharmaceutical companies are turning to contract packagers, and discusses the latest developments

Pw 3130 Tee Noland

Packaging World: What are the key issues and trends you’ve seen develop in the last few years?

Tee Noland:

Further reliance on contractors for packaging and manufacturing expertise, and to do research and development for new products, with a shift in the expertise that used to reside with our clients. There’s so much cost-cutting going on and pressure on Big Pharma because they’re not developing new products as rapidly as they once did. It’s harder to get products approved, so the revenue’s not growing, but they still want to expand their profitability. To do that they have to cut costs, and they’ve found that companies like Pharma Tech have a leaner cost structure in place than they do.

Another trend we’re seeing is that several years ago, Big Pharma companies had separate divisions for Rx and for OTC. Now, because of cost-cutting measures, they realize they don’t need to maintain these separate overhead structures. They can merge OTC and Rx into one effort and still achieve a lot of the benefits that they were trying to achieve by separating them.

Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—Packaging World editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
Annual Outlook Report: Sustainability
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce